rossari · 2020. 10. 21. · e [email protected] w cin: u24100mh2009plc194818 textile i animal...
TRANSCRIPT
ROSSARI making you more competitive
October 20, 2020
Listing Compliance DCS-CRD BSE Limited First Floor, New Trade Wing Rotunda Building,
National Stock Exchange of India Ltd. Exchange Plaza, 5th Floor
Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai 400 023 Fax No.2272 3121/2037 /2039
Stock Code: 543213
Dear Sir /Madam,
Plot No. C/1, 'G 'Block Bandra- Kurla Complex Bandra East Mumbai 400 051 Fax No.2659 8237 /8238
Stock Code: ROSSARI
Sub: Intimation of conference call for investors and analysts under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a conference call for investors and analysts is being organized by the Company on Monday, October 26, 2020 at 5:00 P.M 1ST.
The conference call will be initiated with a brief management discussion on the results for quarter and half year ended September 30, 2020 followed by an interactive Question & Answer session.
Invite in this regard is enclosed for your information and record.
The same may please be taken on record and suitably disseminated to all concerned.
Thanking you,
Yours Sincerely, For Rossari Biotech LimitedL;--T~ £~,c Ec,1y
~~-·Y\-i,, -r~ j.s\ ~f /~ MUMBAI ~))
~- &:,P \ - 'I' Parul Gupta · ~~- . ~,
Company Secretary & Compliance Officer Membership No.: A38895
Encl.: as above
ROSSARI BIOTECH LIMITED (An ISO 9001:2015 & 14001:2015 Certified Company)
Regd. Office: 201 A & B, Ackruti Corporate Park, Next to GE Gardens, LBS Marg, Kanjurmarg 0/'I). Mumbai- 400078. India. T +91 -22-6123 3800 F +91-22-2579 6982
Factory: Plot No. 10 & 11, Survey No. 90/1/10 & 90/11111/1, Kumbhaiwadi, Village Naroli, Dadra & Nagar Haveli (U.T.), Silvassa - 396 235. India. T 0260 - 669 3000
E [email protected] W www.rossari.com CIN: U24100MH2009PLC194818
TEXTILE I ANIMAL HEAL TH & NUTRITION I POLYMER I PHARMA I HLS
Page | 1
Rossari Biotech Limited
Q2 & H1 FY21 Earnings Conference Call
Monday, October 26, 2020 at 5.00 p.m. IST
Rossari Biotech Limited (Rossari) will host a conference call for investors and analysts on Monday, October 26, 2020 at 5:00 pm IST. The conference call will be initiated with a brief management discussion on the Q2 & H1 FY21
results, to be declared on Saturday, October 24, 2020, followed by an interactive Question & Answer
session.
Senior Management team of the Company will be present to address the call.
Dial-in details are as follows:
Timing 5:00 p.m. IST on Monday, October 26, 2020
Universal dial-in + 91 22 6280 1141 / 7115 8042
Local dial-in +91-70456 71221 (Available all over India)
Hong Kong Local Access Number 800 964 448
Singapore Local Access Number 800 101 2045
UK Local Access Number 0 808 101 1573
USA Local Access Number 1 866 746 2133
Pre-registration (Zero wait time to join
the call)
To enable participants to connect to the conference call
without having to wait for an operator, please register
at the below mentioned link:
Please dial the below number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call in time.
®
ROSSARI making you more competitive
Diamond}'"', ... I Oick here to
I ExpressJoin the Call
Page | 2
For more information, please visit www.rossari.com OR contact:
Manasi Nisal Anoop Poojari / Shikha Kshirsagar
Rossari Biotech Limited CDR India
Tel: +91 22 6123 3800 Tel: +91 98330 90434
Email: [email protected] Email: [email protected]
DISCLAIMER:
Certain statements that may be made or discussed at the conference call may be forward-looking
statements. Such forward-looking statements are subject to certain risks and uncertainties like
significant changes in economic environment in India and overseas, tax laws, import duties,
litigation, labour relations etc. Actual results might differ substantially from those expressed or
implied. Rossari Biotech Ltd will not be in any way responsible for any action taken based on such
statements and discussions; and undertakes no obligation to publicly update these forward-looking
statements to reflect subsequent events or circumstances.